Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects

Launched by AJOU UNIVERSITY SCHOOL OF MEDICINE · Jul 26, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the use of a medication called pregabalin to help manage pain after spinal surgery. The main goal is to see how effective different doses of pregabalin are at reducing pain without causing significant side effects. This research will focus on adults aged 65 to 74 who are having spine surgery for issues related to degenerative lumbar disorders.

To participate in this trial, patients must meet certain criteria. They should not have serious health conditions that could complicate their care, such as severe heart or lung issues. Additionally, those who frequently experience dizziness, headaches, or have a history of substance abuse or mental health disorders may not be eligible. Participants can expect to receive either pregabalin or a placebo (a non-active treatment) to compare the effects on their pain levels after surgery. This study is currently not recruiting participants, but it aims to provide valuable insights into better pain management options for patients recovering from spinal surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patient undergoing spine surgery at out institution for degenerative lumbar disorder.
• Exclusion Criteria:
• • ASA classification over 2
• • Patients with dizziness or frequent headache
• • Active alcohol or drug usage
• • Intake of any analgesics daily or 48 hours before surgery
• • Impaired renal and/or hepatic function
• • Diagnosed and being treated for anxiety or depression disorders
• • Coverage from worker's compensation insurance or car insurance.